You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 449 Neoadjuvant cyclic dinucleotides combined with interleukin-2 and anti-PD-1 antibody limit lung metastasis of orthotopic breast tumors through prolonged NK cell activation

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Combination immunotherapies
449 Neoadjuvant cyclic dinucleotides combined with interleukin-2 and anti-PD-1 antibody limit lung metastasis of orthotopic breast tumors through prolonged NK cell activation

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020202015
Dec 20201805
Jan 20213004
Feb 20212103
Mar 20212404
Apr 20212603
May 2021006
Jun 2021003
Jul 2021005
Aug 2021007
Sep 2021004
Oct 202156029
Nov 202128019
Dec 2021602
Jan 2022602
Feb 20221002
Mar 20221000
Apr 20223403
May 20222203
Jun 20222000
Jul 20222804
Aug 20221603
Sep 20221204
Oct 2022605
Nov 20221404
Dec 20221400
Jan 20231600
Feb 20231002
Mar 20231201
Apr 2023203
May 20231403
Jun 2023300
Jul 2023802
Aug 20231000
Sep 20231003
Oct 20231006
Nov 20232806
Dec 20232402
Jan 20241200
Feb 20241200
Mar 2024801
Apr 20241201
May 20241400
Jun 20245802
Jul 20242800
Aug 20241201
Sep 20241203
Oct 20242404
Nov 20241003
Dec 2024808
Jan 20251202
Feb 2025003
Mar 2025007
Apr 2025003
May 2025003
Jun 2025002
Total9720210